Home › Inflammatory Bowel Disease › Washington › Seattle
Inflammatory Bowel Disease clinical trials in Seattle, WA
7 studies for Inflammatory Bowel Disease are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
RecruitingPhase 2
- Site 004, Seattle
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
RecruitingPhase 3
- Seattle Children's Hospital, Seattle
Familial Inflammatory Bowel Disease Early Risk
RecruitingObservational studyHealthy volunteers welcome
- Seattle Children's Hospital, Seattle
Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
RecruitingObservational study
- Seattle Children's Hospital, Seattle
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RecruitingPhase 2
- Mirador Therapeutics Selected Site, Silverdale · 17 mi away
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
RecruitingPhase 2
- Liver institute Northwest, Seattle
Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
Recruiting
- Seattle Children's Hospital, Seattle
Inflammatory Bowel Disease trials in other cities
- New York City, NY15 studies
- Boston, MA14 studies
- St. Louis, MO8 studies
- Washington, DC7 studies
- Miami, FL7 studies
- Houston, TX7 studies
- Orlando, FL7 studies
- Atlanta, GA7 studies
- Durham, NC6 studies
- Philadelphia, PA6 studies
- Cincinnati, OH5 studies
- Round Rock, TX5 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer55 studies
- Cancer (all types)48 studies
- Prostate Cancer45 studies
- Acute Myeloid Leukemia40 studies
- Metastatic Cancer39 studies
- Breast Cancer37 studies
- Colorectal Cancer35 studies
- Lung Cancer34 studies
- Ovarian Cancer29 studies
- Pancreatic Cancer22 studies
- Multiple Myeloma22 studies
- Acute Lymphoblastic Leukemia22 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.